Tripepi G - Search Results

1

Risk reclassification ability of uric acid for cardiovascular outcomes in essential hypertension.

Perticone M, Tripepi G, Maio R, Cimellaro A, Addesi D, Baggetta R, Sciacqua A, Sesti G, Perticone F. Perticone M, et al. Among authors: tripepi g. Int J Cardiol. 2017 Sep 15;243:473-478. doi: 10.1016/j.ijcard.2017.05.051. Epub 2017 May 13. Int J Cardiol. 2017. PMID: 28528984

2

Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients.

Mallamaci F, Zoccali C, Tripepi G, Fermo I, Benedetto FA, Cataliotti A, Bellanuova I, Malatino LS, Soldarini A; CREED Investigators. Mallamaci F, et al. Among authors: tripepi g. Kidney Int. 2002 Feb;61(2):609-14. doi: 10.1046/j.1523-1755.2002.00144.x. Kidney Int. 2002. PMID: 11849403 Free article.

3

Adiponectin in essential hypertension.

Mallamaci F, Zoccali C, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y. Mallamaci F, et al. Among authors: tripepi g. J Nephrol. 2002 Sep-Oct;15(5):507-11. J Nephrol. 2002. PMID: 12455716

4

Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD).

Zoccali C, Mallamaci F, Tripepi G, Parlongo S, Cutrupi S, Benedetto FA, Bonanno G, Seminara G, Fatuzzo P, Rapisarda F, Malatino LS. Zoccali C, et al. Among authors: tripepi g. Kidney Int. 2003 Aug;64(2):579-84. doi: 10.1046/j.1523-1755.2003.00095.x. Kidney Int. 2003. PMID: 12846753 Free article.

5

Prospective study of neuropeptide y as an adverse cardiovascular risk factor in end-stage renal disease.

Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Parlongo S, Cutrupi S, Iellamo D, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Malatino LS. Zoccali C, et al. Among authors: tripepi g. J Am Soc Nephrol. 2003 Oct;14(10):2611-7. doi: 10.1097/01.asn.0000089026.28617.33. J Am Soc Nephrol. 2003. PMID: 14514739

6

Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression.

Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, Cataliotti A, Malatino LS. Zoccali C, et al. Among authors: tripepi g. Kidney Int. 2004 Apr;65(4):1492-8. doi: 10.1111/j.1523-1755.2004.00530.x. Kidney Int. 2004. PMID: 15086493 Free article.

7

Endothelial dysfunction and mild renal insufficiency in essential hypertension.

Perticone F, Maio R, Tripepi G, Zoccali C. Perticone F, et al. Among authors: tripepi g. Circulation. 2004 Aug 17;110(7):821-5. doi: 10.1161/01.CIR.0000138745.21879.27. Epub 2004 Aug 2. Circulation. 2004. PMID: 15289371

8

Prognostic value of 24-hour ambulatory blood pressure monitoring and of night/day ratio in nondiabetic, cardiovascular events-free hemodialysis patients.

Tripepi G, Fagugli RM, Dattolo P, Parlongo G, Mallamaci F, Buoncristiani U, Zoccali C. Tripepi G, et al. Kidney Int. 2005 Sep;68(3):1294-302. doi: 10.1111/j.1523-1755.2005.00527.x. Kidney Int. 2005. PMID: 16105064 Free article.

9

Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease.

Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P, Malatino L. Zoccali C, et al. Among authors: tripepi g. Kidney Int. 2006 Apr;69(7):1253-8. doi: 10.1038/sj.ki.5000114. Kidney Int. 2006. PMID: 16508659 Free article.

10

Inflammation as a mediator of the link between mild to moderate renal insufficiency and endothelial dysfunction in essential hypertension.

Zoccali C, Maio R, Tripepi G, Mallamaci F, Perticone F. Zoccali C, et al. Among authors: tripepi g. J Am Soc Nephrol. 2006 Apr;17(4 Suppl 2):S64-8. doi: 10.1681/ASN.2005121345. J Am Soc Nephrol. 2006. PMID: 16565250

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

558 results

Search Page

Filters